Novartis信息详情
n.诺华公司（瑞士制药公司）
allomer capital innovation───allomer资本创新
innovations now───立即创新
theological innovation───神学创新
novation───n.以新的代替；更新；债券更新；合同变更；（债权人或借债人）旧责任的更新替代
novaculite───n.[岩]均密石英岩
claudia canova───克劳迪娅·卡诺瓦
hurdy gurdy man donovan───赫迪·古迪·曼多诺万
innovation capability───创新能力
n way anova───n向方差分析
novation peak───更替峰
Both Novartis and GSK say they are thinking along these lines.───诺华和史克公司都表示它们也在考虑差别定价的问题。
Agilent and Novartis like to turn specialists into general managers.───安捷伦和诺华喜欢将专家转变为总经理。
Others think Novartis has paid too much.───也有人认为诺华付的太多了。
"If Novartis wanted to make big profits it should have sold Coartem in private markets, where the price per dose can be US$10, " he said.───“如果诺华想要挣钱，它就该将复方蒿甲醚放到私人市场出售，那里的每人份价格可以达到10美元。”他说。
Dr. Weiner wasn't involved in fingolimod's development but said he does consulting work for a number of drug companies, including Novartis.───Weiner博士并没有参与fingolimod的研发，但是他说他为很制药公司提供咨询，包括诺华公司。
Novartis recently lost a patent case in India and said it had changed its plans to invest in R&D in India.───诺华最近在印度输了一场专利官司，并且表示它将改变在印度的研发投资计划。
Novartis defended the decision, saying that it had planned to register the drug long before winning the award.───诺华对这个决定进行了辩护，它说它在获得这个奖的很久之前就打算注册该药了。
Although it will be at least five years before any new drugs emerge, there may be subtle marketing benefits for Novartis in the meantime.───新药问世尽管至少需时五年，但诺华可能同时获取微妙的行销利益。
Novartis insists that it sells Coartem at cost price and has made no profits out of it.───诺华坚称它一直都是以成本价在销售复方蒿甲醚，并没有从中挣得任何利润。
Novartis announced last week (17 November) that half a dose of its A(H1N1) vaccine is enough to provide immunity to the virus.
Novartis renewed its commitment to donate an unlimited supply of multidrug therapy and loose clofazimine for leprosy and its complications.
Novartis, a Swiss drug company, is currently embroiled in a sticky legal battle over India's refusal to grant a patent for its leukaemia drug Glivec.
We at Novartis will lead in ￡ sterling but will be prepared to offer in euros if asked.
The Novartis team used a low risk philosophy, which necessarily cost more, though it provided guarantees against disaster.
It's shopping list includes drug-makers like Novartis, the beleagured oil giant BP, advertising concern WPP and Barclays bank.
But, argues Saini, if companies like Novartis want to encourage research and development in poor countries, they would do better to litigate less and innovate more themselves.
The Novartis team put up a valiant fight, but admit defeat.
Novartis, East Hanover, NJ)is the first selective signal transduction inhibitors in the management of tumour malignancies.